Research

Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Going into science: Women scientists at Boston Children's offer advice to girls

We gathered women scientists from across Boston Children’s Hospital and asked them to advise girls wanting to enter the field. Hear what they had to say, and go in depth here for more wise words and a taste of what they’re investigating.

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 10/24/2020 8:00:00 PM
New research from @PrecVaccines emerges about the development of a newborn’s immune system. @Tech_Networks talks to… https://t.co/ghOiUIJ7mt
BCH Innovation News @BCH_Innovation 10/24/2020 5:00:01 PM
Can #trifluoperazine, a drug normally used to treat psychosis, help people with Diamond-Blackfan #anemia make… https://t.co/VdC4jE04fF
BCH Innovation News @BCH_Innovation 10/24/2020 1:00:01 PM
“Our research suggests we as healthcare providers need to pay more attention to families with limited English profi… https://t.co/RdUcZqaxwF
BCH Innovation News @BCH_Innovation 10/23/2020 6:00:01 PM
A potential treatment for #DiamondBlackfananemia swims into view: Trifluoperazine, a #calmodulin inhibitor used as… https://t.co/iolsGs4hUX
BCH Innovation News @BCH_Innovation 10/23/2020 1:00:01 PM
How do cells harbor memories of #inflammation, and can we promote or erase them to treat disease? @BostonChildrens'… https://t.co/hrpxFfn0fn
BCH Innovation News @BCH_Innovation 10/22/2020 1:00:02 PM
Congratulations to @ordovas_phd for being selected as a Robertson Investigator by the New York Stem Cell Foundation… https://t.co/JVi5tFCJBc
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer